Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Study to Determine the Immunopheotype of Locally Advanced Rectal Adenocarcinoma and Its Correlation With the Efficacy of Neoadjuvant Chemoradiotherapy

NCT02017509 is registered in ClinicalTrials.gov with Providence Health & Services as lead sponsor.

NCT NCT02017509
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02017509 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Study to Determine the Immunopheotype of Locally Advanced Rectal Adenocarcinoma and Its Correlation With the Efficacy of Neoadjuvant Chemoradiotherapy
Lead sponsor
Providence Health & Services
Phase
Observational
Overall status
Completed
Start date
January 24, 2014
Completion date
July 17, 2018
Enrollment
3 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

cancer of the rectum, neoplasms, rectal, rectal adenocarcinoma, rectal cancer, rectal tumors